Health
Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy – News-Medical.Net
The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen,…
The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen™, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate…
Continue Reading
-
General21 hours agoHome of Andrii Yermak, Zelenskyy’s chief of staff, raided by anti-corruption unit
-
Business13 hours agoIs this the best ASX ETF to diversify your portfolio with?
-
General8 hours agoLiberals go back to basics after crawling to year’s end
-
Business14 hours ago3 of the best ASX ETFs to build significant wealth